Peter A. Thompson Transaction History

Date Transaction Value Shares Traded Form
Dec 29 2021
SELL
Open market or private sale
$820,120 $20.3 p/Share
40,400
Dec 21 2021
SELL
Open market or private sale
$2,268,600 $19.0 p/Share
119,400
Dec 16 2021
SELL
Open market or private sale
$7,500,231 $19.07 p/Share
393,300
Jun 15 2021
BUY
Open market or private purchase
$11,999,501 $17.0 p/Share
705,853
Jun 15 2021
BUY
Conversion of derivative security
-
2,336,911

Also insider at

SBTX
Silverback Therapeutics, Inc. Healthcare
ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
PRVL
Prevail Therapeutics Inc.
DBTX
Decibel Therapeutics, Inc. Healthcare
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
PMVP
PMV Pharmaceuticals, Inc. Healthcare
PAT

Peter A. Thompson

Director
Burlingame, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Track Activities on JANX